Blood Transfusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 4.97 Billion
CAGR (2026-2031)	5.8%
Fastest Growing Segment	Apheresis Systems
Largest Market	North America
Market Size (2031)	USD 6.97 Billion

Market Overview

The Global Blood Transfusion Devices Market is projected to grow from USD 4.97 Billion in 2025 to USD 6.97 Billion by 2031 at a 5.8% CAGR. Blood transfusion devices are specialized medical instruments designed to facilitate the safe and controlled intravenous administration of blood or blood products from a donor to a recipient, encompassing components such as filters, tubing, and access catheters. The market for these devices is primarily driven by the increasing global incidence of surgical procedures, trauma cases, and chronic diseases necessitating transfusions. Furthermore, the rising prevalence of conditions such as anemia, cancer, and kidney disease requiring recurrent transfusions significantly contributes to market expansion. According to the AABB 2025 Annual Meeting abstract, overall institutional packed red blood cell transfusions in 2024 demonstrated a sustained reduction of approximately 15-23% compared to 2019 baseline figures of 11,850 units.

A significant challenge impeding market expansion is the substantial capital and operational costs associated with advanced transfusion technologies. These expenses can create financial barriers to adoption, particularly within low and middle income countries, thereby limiting access to modern transfusion care solutions globally.

Key Market Drivers

The increasing volume of surgical procedures significantly drives the demand for blood transfusion devices, as numerous interventions, particularly complex and prolonged surgeries, require blood transfusions to manage blood loss and maintain patient stability. Advances in surgical techniques, coupled with expanding access to healthcare, are contributing to a steady rise in surgical volumes globally. For instance, according to a systematic review published in PMC in November 2025, projections to 2050 indicate that Total Hip Arthroplasty (THA) volumes are expected to rise by 121% to over 200%, and Total Knee Arthroplasty (TKA) volumes by at least 130% across various countries, underscoring a continuous increase in procedures that frequently necessitate transfusion support.

Furthermore, the growing prevalence of blood disorders and chronic diseases constitutes another primary driver for the blood transfusion devices market. Conditions such as severe anemia, thalassemias, sickle cell disease, and certain cancers frequently rely on regular or intermittent blood transfusions for patient management. The widespread impact of these conditions is substantial; according to the World Health Organization's (WHO) 2025 edition of global anemia estimates, 30.7% of women aged 15-49 years suffered from anemia in 2023. This sustained need for transfusions directly boosts the demand for efficient transfusion equipment. According to the American Red Cross, in January 2026, the national blood supply fell approximately 35% over the preceding month, highlighting critical supply pressures impacting the availability of blood for transfusions.

Download Free Sample Report

Key Market Challenges

The substantial capital and operational costs associated with advanced transfusion technologies present a significant impediment to the growth of the Global Blood Transfusion Devices Market. These considerable expenses establish financial barriers for healthcare providers, particularly impacting adoption rates within low and middle-income countries. The high initial investment required for sophisticated equipment, coupled with ongoing maintenance and operational expenditures, limits the ability of many institutions to upgrade or acquire modern transfusion care solutions.

This financial strain directly hampers market expansion by constraining purchasing power and delaying technological integration. For instance, according to an AABB 2025 Annual Meeting abstract, total spending on blood products across a hospital system increased by 19.8% from $12.8 million in 2020 to $15.3 million in 2024. Such rising operational costs for blood products themselves reduce the available budget for capital investments in new and improved blood transfusion devices, thereby restricting market penetration and the widespread implementation of advanced systems globally.

Key Market Trends

Increased automation in blood collection and processing devices represents a pivotal trend, enhancing efficiency and minimizing manual errors in the preparation of blood products. This trend directly influences the market by driving demand for advanced automated systems that streamline laboratory workflows and improve sample handling accuracy. For example, the implementation of an automated immunohematology analyzer at a large academic and research hospital saved approximately two hours of technologist time per run during red blood cell antigen testing, as noted in an AABB 2025 Annual Meeting abstract. Such efficiency gains are critical for blood banks and transfusion services to manage increasing volumes of blood products with improved turnaround times and consistent quality.

Concurrently, the growth in home-based and point-of-care transfusion device utilization signifies a significant shift in healthcare delivery, moving transfusions closer to patients' environments outside traditional hospital settings. This trend expands the accessibility of transfusion therapy, particularly for patients requiring frequent or urgent transfusions. The market is consequently experiencing increased demand for portable, user-friendly devices capable of safe and effective blood product administration in diverse non-clinical locations. According to America's Blood Centers, in February 2026, the inclusion of emerging national data on prehospital blood transfusions illustrates that such lifesaving procedures are increasingly happening before many patients even reach the hospital. This highlights a growing operational scope for transfusion devices in emergency and home care scenarios.

Segmental Insights

Apheresis Systems represent the fastest-growing segment within the Global Blood Transfusion Devices Market. This rapid expansion is primarily driven by the increasing global prevalence of chronic and autoimmune diseases, alongside various hematological and neurological disorders that necessitate targeted blood component therapies. Furthermore, continuous technological advancements in apheresis equipment, offering enhanced precision, automation, and safety features for the selective collection of plasma, platelets, or leukocytes, contribute significantly to their heightened adoption. The rising demand for plasma-derived therapies and growing initiatives to bolster blood donation programs also logically support this segmental growth.

Regional Insights

North America leads the global blood transfusion devices market due to its robust healthcare infrastructure and substantial healthcare expenditure. The region benefits from stringent regulatory oversight, particularly from the U.S. Food and Drug Administration (FDA), which ensures high standards for blood safety and device efficacy. This regulatory environment fosters the adoption of advanced transfusion technologies, including pathogen reduction systems. Furthermore, a high volume of surgical procedures, an aging population, and a significant prevalence of chronic diseases drive a consistent demand for blood products and associated devices. The presence of key market players further strengthens North America’s dominant position in this sector.

Recent Developments

• In September 2025, breakthrough research into a new "blood on demand" technology was announced, promising to revolutionize emergency transfusions. Researchers from the Universities of Manchester and Leeds collaborated with the industry partner CryoLogyx to develop a transformative method for freezing human red blood cells. This innovative technique significantly reduces the post-thaw washout time for cryopreserved blood, decreasing it by over 50 minutes compared to traditional glycerol methods. This advancement directly impacts the global blood transfusion devices market by enabling faster preparation and deployment of frozen blood, particularly in urgent medical situations, disaster zones, or military operations, thereby enhancing the efficiency and accessibility of blood products.
• In August 2025, Levisonics Inc., a medical device startup, initiated the testing phase for a novel diagnostic device designed to quickly detect life-threatening blood-clotting issues in trauma patients. This followed the receipt of a substantial $4.3 million grant from the U.S. Department of Defense, supporting extensive real-world testing. The battery-powered acoustic tweezing device, approximately the size of a small microwave, is engineered for portability and emergency use in combat zones, field hospitals, and emergency rooms. This breakthrough research and development activity by a company is poised to significantly influence the global blood transfusion devices market by providing rapid, critical information for precise blood transfusion decisions, reducing diagnostic wait times to under 20 minutes.
• In May 2025, Delcon, a global leader in medical devices for blood collection and processing, forged a strategic partnership with Versiti, Inc., a prominent national organization in blood health innovation. This collaboration marked the implementation of Delcon's advanced blood collection scale technology across Versiti’s operations. The partnership aimed to establish new standards for donor experience and operational efficiency within blood centers, directly impacting the blood transfusion devices market by improving the accuracy and management of daily blood donations. Versiti, Inc. became the initial U.S. blood center to adopt these customized, branded collection scales, integrating high-performance technology with a focus on donor care.
• In May 2025, SATO Healthcare Co., Ltd., a pioneer in automatic identification solutions, presented its comprehensive PJM RFID Vein-to-Vein solutions at the International Society of Blood Transfusion (ISBT) Congress. These solutions, which are compliant with ISBT guidelines and ISO18000-3 Mode 2 standards, aim to enhance traceability and operational efficiency throughout the entire blood management process. The company showcased capabilities in blood collection, processing, storage, and transportation. SATO also introduced Sentinel Eyes, an intelligent system for remote management and secure delivery of blood products, developed in collaboration with partners GPI and B Medical Systems. This initiative demonstrates significant advancements in technology for the global blood transfusion devices market.

Key Market Players

• Immucor Inc.
• Becton Dickinson and Company
• B. Braun Melsungen AG
• Terumo Corporation
• Grifols SA
• Kaneka Corporation
• Fresenius Kabi AG
• Haemonetics Corporation
• Macopharma SA
• Ecomed Solutions, LLC.

By Product	By End Use	By Region
Apheresis Systems Infusion Devices Blood Warmers Venous Access Devices Filters Others	Hospital Ambulatory Surgical Centers Dialysis Centers Blood Bank Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Transfusion Devices Market, By Product:

• Apheresis Systems
• Infusion Devices
• Blood Warmers
• Venous Access Devices
• Filters
• Others

• Blood Transfusion Devices Market, By End Use:

• Hospital
• Ambulatory Surgical Centers
• Dialysis Centers
• Blood Bank
• Others

• Blood Transfusion Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE